The symposium will start on Sunday (28^th) at 2 pm and end on Tuesday (30^th) at 2 pm.

Registration deadline: April, 7th.

Accumulating evidences support the importance of RNA biology in the hallmarks of cancer. Post-transcriptional steps of gene expression (pre-mRNA splicing, polyadenylation, stability, translation, localization and modifications) as well as the functions of non-coding RNAs are increasingly diverse. It is therefore challenging to comprehend this complexity in the context of cancer.

The internationally renowned experts invited to this symposium will present the recent advances in our understanding of RNA biology in cancer. This will be complemented by at least 10 selected talks, as well as poster presentations.

The symposium is intended to bring together RNA and cancer biologists. It is expected that the small size of the attendance (max. 150) will foster stimulating discussions that will lead to innovative collaborations.

This symposium is a satellite meeting of “RNA 2017”, the meeting of the RNA Society (Prague, May 30 – June 3).

Sessions:

- Regulators of RNA metabolism as oncoproteins and tumor suppressors
- Oncogenic signalling to RNAs and anti-cancer targeted therapies
- RNA modifications in cancer development and progression
- Extracellular RNA trafficking
- RNA-based reprograming of cancer cell metabolism
- Immune response and RNA biology

Confirmed speakers:

Keynote speaker:

Nahum SONENBERG (Montreal, CA)

Invited Speakers:

Omar ABDEL-WAHAB (New York, US)      
Reuven AGAMI (Amsterdam, NL)
Chuan HE (Chicago, US)
Carmit LEVY (Tel Aviv, IL)
Kazuko NISHIKURA (Philadelphia, US)
Esther NOLTE-T HOEN (Utrecht, NL)
Caroline ROBERT (Villejuif, FR)
Frank SLACK (Boston, US)
Marisol SOENGAS (Madrid, SP)
Martin TURNER (Cambridge, UK)